M1 Kliniken AG: Strong Growth in 2024 and Strategic Realignment in Focus

M1 Kliniken AG has continued its growth trajectory in the fiscal year 2024, benefiting particularly from the high-margin beauty segment. The group's revenue increased by 7% to €339.2 million, while EBITDA rose by 52% to €32.0 million. EBIT increased by 70% to €26.8 million. EPS reached €0.85, and free cash flow improved to €24.9 million. The beauty segment developed particularly dynamically, achieving a revenue growth of 30% to €91.7 million. M1 Med Beauty has thus solidified its position as the European market leader in aesthetic medical...